IP Library › Assignment 030741/0511
Patent Assignment
Reel/Frame 030741/0511

Change of Name

Recorded: 2013-07-05 Pages: 12
Assignor
WATSON PHARMACEUTICALS, INC.
Executed: 2013-01-21
Assignee
ACTAVIS, INC.
400 INTERPACE PARKWAY, MORRIS CORPORATE CENTER III, PARSIPPANY, NEW JERSEY, 07054
Covered Properties (3)
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 7,785,627 →
Application: 10/664,803 →
Publication: US 2004/0106660
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 7,959,946 →
Application: 10/777,542 →
Publication: US 2004/0161462
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 8,309,125 →
Application: 12/835,945 →
Publication: US 2010/0316708
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2009
From: ANDRX LABS, LLC
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 022413/0374 →
Assignment of Assignor's Interest Jan 20, 2017
From: ALLERGAN FINANCE, LLC
To: ACTAVIS HOLDCO US, INC.
Reel/Frame 041449/0799 →
Change of Name Jan 20, 2017
From: ACTAVIS, INC.
To: ALLERGAN FINANCE, LLC
Reel/Frame 041459/0788 →